Navigation Links
Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
Date:2/19/2008

e passcode for the conference call is 82632306. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=RGRXWMYHV

A telephone replay of the call will also be available for 48 hours. Callers may access the telephone replay by dialing (domestic) 888-286-8010 or 617-801-6888 (international), passcode 10008184.

About Community Acquired Pneumonia (CAP)

CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. Approximately 5.6 million cases of CAP are diagnosed each year in the United States with 10 million physician visits, resulting in an estimated total annual expenditure of $2 billion dollars for prescribed antibiotics to treat CAP. CAP is potentially fatal if not treated properly, and the bacteria that cause CAP are developing resistance to current standard of care treatments.

Macrolides and penicillins are currently the first-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections. In in vitro tests, cethromycin appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance.

In addition to its utility in CAP, cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has des
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at the Rodman & Renshaw ... NY at 9:35 a.m. ET on Thursday, September ... to the public via live audio webcast which can be ... corporate website at http://www.aethlonmedical.com . The webcast will be ...
(Date:9/2/2015)... , Sept. 2, 2015  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... Finkelstein , President and Chief Executive Officer, will ... Renshaw Global Investment Conference, sponsored by H.C. ... held September 8-10, 2015 at the St. Regis ...
(Date:9/2/2015)... MENLO PARK, Calif. , Sept. 2, 2015 ... company today announced that Jim Pekarsky , chief executive ... & Renshaw 17th Annual Global Investment Conference taking place, September ... York . Mr. Pekarsky is scheduled to ... in Astor Suite A (2 nd floor). ...
Breaking Medicine Technology:RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3
... at ASCO for the First ... ... Avastin (bevacizumab),significantly improves the time patients with metastatic breast cancer ... used chemotherapy called docetaxel (Taxotere),compared with docetaxel alone. These findings were ...
... - Thousands Of Patients Benefit Provided From Avastin-Based ... data will be presented at the,44th annual meeting ... in,Chicago confirming that Avastin-based therapy is essential for ... separate data,presentations will be made with highlights including:, ...
Cached Medicine Technology:Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer 2Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer 3Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer 3
(Date:9/2/2015)... ... September 02, 2015 , ... ... large stream of mixed documents that include EOBs, payments, and payment related documents. ... the data needed to reconcile their billing, with one efficient process and interface,“ ...
(Date:9/2/2015)... Pittsburgh, PA (PRWEB) , ... September 02, 2015 ... ... the Health Sciences clinical and academic partnership has earned international recognition as a ... rare genetic disorder that can cause sudden, catastrophic internal bleeding and stroke. ...
(Date:9/2/2015)... Neb. (PRWEB) , ... September ... ... of the nation’s largest and fastest-growing interim clinical staffing companies, has completed ... and Heritage Group.         , BPOC and Heritage Group each offer ...
(Date:9/2/2015)... ... ... Amada Senior Care, premier provider of in-home care and assisted living placement ... location. Amada franchise partners Mike and Mell Fleming came to the senior care industry ... years in medical device sales while Mell spent over 30 years as a registered ...
(Date:9/2/2015)... Dallas, TX (PRWEB) , ... September 02, 2015 , ... ... American Cancer Society, a woman’s risk of getting ovarian cancer in her lifetime is ... receive a new diagnosis of ovarian cancer, and 14,000 will die. , There ...
Breaking Medicine News(10 mins):Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3
... It appears to act as ,sham feeding, that stimulates ... (HealthDay News) -- Chewing gum helps improve recovery of ... has been surgically removed, according to British researchers who ... , The inability of the intestines to pass contents ...
... new study say aim is to generate awareness of the ... patients are less likely to be transported to an official ... study found. , The finding was based on a review ... (EMS) records. And it suggests that the difference in care ...
... Trends in Cosmetic Surgery and Health Risks ... for ... today released a new,report that reveals the impact of idealized, airbrushed ... of American women and girls. The report, Beauty at Any Cost,shows ...
... CHAPEL HILL Families with disabled children are struggling to ... and to pay for needed health and dental care. ... North Carolina at Chapel Hill, these challenges are now falling ... previous research has found. , These latest findings show ...
... American Medical,Association (AMA) Foundation awarded the Arthur N. ... grew up in Sitka, Alaska and attends,the University ... a,$5,000 scholarship to help defray medical school expenses. ... medical student who graduated,from a high school in ...
... PHILADELPHIA, Aug. 18 Independence Blue Cross (IBC),today ... the American Diabetes,Association,s (ADA,s) Step Out: Walk to ... October 4, 2008., The new family- and ... efforts to stem the growing diabetes epidemic by ...
Cached Medicine News:Health News:Gum Chewing May Speed Colon Surgery Recovery 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 3Health News:America's Beauty Obsession Poses Serious Consequences for Women and Girls, Report Reveals 2Health News:UNC study: 'chilling' hardship rates among families raising disabled children 2Health News:UNC study: 'chilling' hardship rates among families raising disabled children 3Health News:AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska 2Health News:Independence Blue Cross Signs on as Presenting Sponsor of American Diabetes Association's Step Out: Walk to Fight Diabetes in Philadelphia 2Health News:Independence Blue Cross Signs on as Presenting Sponsor of American Diabetes Association's Step Out: Walk to Fight Diabetes in Philadelphia 3Health News:Independence Blue Cross Signs on as Presenting Sponsor of American Diabetes Association's Step Out: Walk to Fight Diabetes in Philadelphia 4
... II test is also available with Inverness ... greatly reduces the hands-on time required to ... testing. The Fecal-Quik-Prep device is a unique ... amount of hands-on time required to prepare ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: